
Global Cord Blood Corporation CO
Geschäftsbericht 2022
hinzugefügt 16.08.2022
Global Cord Blood Corporation P/E 2011-2025 | CO
P/E Jährlich Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.485 | 0.957 | 0.775 | 18.4 | 30.8 | 28.8 | 32.8 | 28.1 | 15.6 | 12 | 10.8 | 16.9 |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 32.8 | 0.485 | 16.4 |
P/E anderer Aktien in der Diagnostik & Forschung
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-37.1 | $ 18.68 | -3.56 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 20.72 | -3.9 % | $ 223 M | ||
|
Co-Diagnostics
CODX
|
-0.988 | $ 0.23 | -2.72 % | $ 6.75 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 39.21 | -0.47 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
39 | $ 230.38 | 0.02 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.32 | 2.79 % | $ 293 M | ||
|
BioNano Genomics
BNGO
|
-0.0317 | $ 1.5 | -1.11 % | $ 1.91 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
-10.8 | $ 101.55 | -0.02 % | $ 18.8 B | ||
|
DexCom
DXCM
|
90.1 | $ 67.58 | 0.01 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 26.45 | -1.01 % | $ 800 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-2.74 | $ 18.97 | -2.62 % | $ 1.02 B | ||
|
Celcuity
CELC
|
-3.57 | $ 101.5 | -0.73 % | $ 4 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-0.00564 | $ 3.18 | -0.62 % | $ 101 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
26 | $ 226.1 | -0.36 % | $ 41 B | ||
|
Guardant Health
GH
|
-13.4 | $ 101.78 | -1.17 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
-7.64 | $ 6.35 | -2.01 % | $ 575 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.191 | $ 4.95 | -0.85 % | $ 2.66 M | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 7.19 | 0.84 % | $ 1.56 B | ||
|
National Research Corporation
NRC
|
32.6 | $ 18.72 | 0.32 % | $ 459 M | ||
|
Illumina
ILMN
|
-13.4 | $ 133.49 | -1.09 % | $ 21.2 B | ||
|
Charles River Laboratories International
CRL
|
385 | $ 202.84 | -0.35 % | $ 10.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 174.86 | -0.63 % | $ 19.4 B | ||
|
Biodesix
BDSX
|
-2.14 | $ 6.77 | -0.73 % | $ 878 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.19 | 0.3 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
28.3 | $ 252.44 | -0.6 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 182.31 | -0.29 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
42.4 | $ 682.03 | -0.94 % | $ 56.2 B | ||
|
Personalis
PSNL
|
-3.12 | $ 8.04 | -1.23 % | $ 476 M | ||
|
Lantheus Holdings
LNTH
|
20.7 | $ 66.81 | 0.15 % | $ 4.62 B | ||
|
Mettler-Toledo International
MTD
|
34.6 | $ 1 411.55 | -0.62 % | $ 30 B | ||
|
Quidel Corporation
QDEL
|
13 | $ 29.19 | -0.38 % | $ 1.23 B | ||
|
Agilent Technologies
A
|
34.7 | $ 137.82 | -0.41 % | $ 41.9 B | ||
|
RadNet
RDNT
|
1.32 K | $ 72.76 | -0.53 % | $ 5.31 B |